10x Genomics, Inc. TXG Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s return on invested capital?
- 10x Genomics, Inc. (TXG) reported return on invested capital of -9.5% in Q1 2026.
- How has 10x Genomics, Inc.'s return on invested capital changed year-over-year?
- 10x Genomics, Inc.'s return on invested capital increased by 76.2% year-over-year, from -39.9% to -9.5%.
- What is the long-term trend for 10x Genomics, Inc.'s return on invested capital?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s return on invested capital has grown at a -54.9% compound annual growth rate (CAGR), from -760.3% to -14.3%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.